Medtronic (MDT) Cash & Current Investments (2016 - 2026)
Medtronic (MDT) has disclosed Cash & Current Investments for 14 consecutive years, with $8.4 billion as the latest value for Q1 2026.
- Quarterly Cash & Current Investments rose 5.82% to $8.4 billion in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $8.4 billion through Jan 2026, up 5.82% year-over-year, with the annual reading at $9.0 billion for FY2025, 11.99% up from the prior year.
- Cash & Current Investments hit $8.4 billion in Q1 2026 for Medtronic, up from $8.3 billion in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $11.4 billion in Q4 2022 to a low of $7.7 billion in Q4 2023.
- Historically, Cash & Current Investments has averaged $8.9 billion across 5 years, with a median of $8.3 billion in 2024.
- Biggest five-year swings in Cash & Current Investments: plummeted 32.34% in 2023 and later increased 11.99% in 2025.
- Year by year, Cash & Current Investments stood at $11.4 billion in 2022, then tumbled by 32.34% to $7.7 billion in 2023, then grew by 3.3% to $8.0 billion in 2024, then grew by 4.23% to $8.3 billion in 2025, then grew by 0.67% to $8.4 billion in 2026.
- Business Quant data shows Cash & Current Investments for MDT at $8.4 billion in Q1 2026, $8.3 billion in Q4 2025, and $8.1 billion in Q3 2025.